SF3B1 and B-cell chronic lymphocytic leukemia: Moreover, DNA methylation studies recently identified a distinct clinico-biological CLL subgroup, termed intermediate-CLL, characterized by moderately mutated IGHV genes (95–98% identity to the germline sequence), enrichment in subset #2 cases, SF3B1 mutations, and an intermediate TTFT with relatively favorable OS [46,47,48].